Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11340-11346
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11340
Figure 1
Figure 1 MiR-133a expression is downregulated in colorectal cancer patients. A: MiR-133a expression was determined by quantitative real-time polymerase chain reaction and normalized against U6 RNA (an endogenous control). Expression was compared between 169 pairs of colorectal cancer tissues (T) and adjacent non-tumorous tissues (N); B: Fold changes of miR-133a of individually matched samples. Data are represented as log2 fold change (T/N) (< -1, under-expression; -1, unchanged; > 1, over-expression).
Figure 2
Figure 2 Kaplan-Meier curves for overall-survival in 169 colorectal cancer patients. A: MiR-133a level; B: Local invasion; C: Lymph node metastasis; D: Tumor-node-metastasis stage (TNM).